Analytical Data
-
Gene name
CSRP2
- Application
-
Alternative Names
CSRP2；LMO5；SMLIM;Cysteine and glycine-rich Protein 2
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q16527
-
Expression Region
1-193aa
-
AA Sequence
MGSSHHHHHH SSGLVPRGSH MGSHMPVWGG GNKCGACGRT VYHAEEVQCD GRSFHRCCFL CMVCRKNLDS TTVAIHDEEI YCKSCYGKKY GPKGYGYGQG AGTLNMDRGE RLGIKPESVQ PHRPTTNPNT SKFAQKYGGA EKCSRCGDSV YAAEKIIGAG KPWHKNCFRC AKCGKSLEST TLTEKEGEIY CKGCYAKNFG PKGFGYGQGA GALVHAQ
-
Molecular Weight
24 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
The study of the CSRP2 (Cysteine and Serine Rich Protein 2) recombinant protein has gained significant attention due to its critical role in various cellular processes and its implications in human diseases. CSRP2 is a member of the CSRP family, known for its involvement in muscle development and differentiation, as well as in cardiac and skeletal muscle function. Abnormal expression of CSRP2 has been linked to several pathologies, including cardiomyopathies and other muscular disorders. Recent advances in recombinant DNA technology have enabled the production of CSRP2 in a laboratory setting, allowing for detailed characterization of its structure and function. Researchers aim to elucidate the specific molecular mechanisms by which CSRP2 regulates cellular activities, particularly in muscle tissues. This knowledge could lead to potential therapeutic targets for muscle-related diseases. Additionally, understanding CSRP2's interactions with other proteins may provide insights into its role in signaling pathways important for cell growth and survival. Overall, the exploration of CSRP2 recombinant protein is a promising area of research that may yield significant contributions to both basic biology and clinical applications, enhancing our understanding of muscle biology and disease mechanisms.
